Ascentage Pharma Group International (HKSE:06855) Net Margin % : -660.02% (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Ascentage Pharma Group International Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Ascentage Pharma Group International's Net Income for the six months ended in Dec. 2023 was HK$-572.4 Mil. Ascentage Pharma Group International's Revenue for the six months ended in Dec. 2023 was HK$86.7 Mil. Therefore, Ascentage Pharma Group International's net margin for the quarter that ended in Dec. 2023 was -660.02%.

The historical rank and industry rank for Ascentage Pharma Group International's Net Margin % or its related term are showing as below:

HKSE:06855' s Net Margin % Range Over the Past 10 Years
Min: -10202.9 Med: -2338.06 Max: -416.98
Current: -416.98

HKSE:06855's Net Margin % is ranked worse than
63.43% of 1020 companies
in the Biotechnology industry
Industry Median: -152.785 vs HKSE:06855: -416.98

Ascentage Pharma Group International Net Margin % Historical Data

The historical data trend for Ascentage Pharma Group International's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascentage Pharma Group International Net Margin % Chart

Ascentage Pharma Group International Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Margin %

Get a 7-Day Free Trial

-10,202.90

-5,442.48

-2,803.37

-421.02

-416.98

Ascentage Pharma Group International Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Net Margin %	Get a 7-Day Free Trial									-2,714.85	-424.73	-417.90	-281.95	-660.02

Competitive Comparison of Ascentage Pharma Group International's Net Margin %

For the Biotechnology subindustry, Ascentage Pharma Group International's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ascentage Pharma Group International's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ascentage Pharma Group International's Net Margin % distribution charts can be found below:

* The bar in red indicates where Ascentage Pharma Group International's Net Margin % falls into.

Ascentage Pharma Group International Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Ascentage Pharma Group International's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-1012.442	/	242.801
	=	-416.98 %

Ascentage Pharma Group International's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin	=	Net Income (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-572.359	/	86.718
	=	-660.02 %

Ascentage Pharma Group International (HKSE:06855) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Ascentage Pharma Group International Net Margin % Related Terms

Thank you for viewing the detailed overview of Ascentage Pharma Group International's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Ascentage Pharma Group International (HKSE:06855) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascentage Pharma Group International (HKSE:06855) » Definitions » Net Margin %

Comparable Companies

Traded in Other Exchanges

ASPHF:USA 36X:Germany

Address

68 Xinqing Road, Suzhou Industrial Park, Jiangsu, Suzhou, CHN, 215000

Website

https://www.ascentagepharma.com

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis, or programmed cell death. The company's geographical segments include the United States and Mainland China.

Executives

Ascentage Limited
Gao Sharon Xia
Guo Edward Ming
Healthquest Pharma Limited
Li Ju-yun
Wang Shaomeng
Yang Dajun
Zhai Yifan
South Dakota Trust Company Llc	2301 Trustee
Jpmorgan Chase & Co.	2201 Interest of corporation controlled by you
Tian Yuan	2201 Interest of corporation controlled by you
Zhao Li	2202 Interest of your spouse
Xian Jin Zhi Zao Chan Ye Tou Zi Ji Jin You Xian He Huo	2201 Interest of corporation controlled by you
Xian Jin Zhi Zao Chan Ye Tou Zi You Xian Gong Si	2101 Beneficial owner
Guo Tou Chuang Xin Tou Zi Guan Li You Xian Gong Si	2201 Interest of corporation controlled by you

Ascentage Pharma Group International (HKSE:06855) Headlines

No Headlines